USD10
IMRX Shares
About ImmuneeringImmuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
USD10
IMRX Shares
About ImmuneeringImmuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$349.13M
OPEN PRICE
$5.19
LOW (1Y)
$1.10
HIGH (1Y)
$10.08
LOW (24H)
$5.19
HIGH (24H)
$5.59
VOLUME (24H)
$598.39K
12.44%
Price history
Time | Price | Change |
|---|---|---|
Today | $5.19 | |
1 Day | $5.45 | |
1 Week | $4.99 | |
1 Month | $5.18 | |
1 Year | $1.35 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
